A powerful new combination that works more efficiently against mastitis.
About Ubrolexin® Learn more about the combination Learn more about synergy Clinical efficacy of Ubrolexin FAQs and more

Welcome!

Ubrolexin® is a novel, broad spectrum antibiotic treatment delivering a potent bactericidal activity against both gram positive and gram negative mastitis-causing bacteria i.e. on both ends of the pathogen spectrum.

Ubrolexin® is a powerful combination of two effective antibiotics (Cefalexin and Kanamycin) which show a synergistic antibacterial activity: the effect of Cefalexin is enhanced by Kanamycin and vice versa.

Find out more about Ubrolexin here.

A  A  A 

© Boehringer Ingelheim Animal Health GmbH, Germany |  * Legal disclaimer |  Privacy Policy |  Terms of Use |  Contact us |  Local sites